These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2396863)

  • 1. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
    Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
    Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.
    Richard S; Guerret S; Gerard F; Tebib JG; Vignon E
    Rheumatology (Oxford); 2000 Jan; 39(1):50-4. PubMed ID: 10662873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?
    Kremer JM; Koff R
    Semin Arthritis Rheum; 1992 Jun; 21(6):376-86. PubMed ID: 1626283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
    Kremer JM; Kaye GI; Kaye NW; Ishak KG; Axiotis CA
    Arthritis Rheum; 1995 Sep; 38(9):1194-203. PubMed ID: 7575712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and histologic hepatic abnormalities: a meta-analysis.
    Whiting-O'Keefe QE; Fye KH; Sack KD
    Am J Med; 1991 Jun; 90(6):711-6. PubMed ID: 1828327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
    Kremer JM; Lee RG; Tolman KG
    Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate.
    Chandran G; Ahern MJ; Hall PD; Geddes R; Smith MD; Hill W; Harley JH
    Br J Rheumatol; 1994 Oct; 33(10):981-4. PubMed ID: 7921763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
    Park SH; Choe JY; Kim SK
    Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
    Rau R; Karger T; Herborn G; Frenzel H
    J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
    Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
    Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity after long-term methotrexate therapy.
    Reynolds FS; Lee WM
    South Med J; 1986 May; 79(5):536-9. PubMed ID: 3704718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
    Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
    Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients.
    Brick JE; Moreland LW; Al-Kawas F; Chang WW; Layne RD; DiBartolomeo AG
    Semin Arthritis Rheum; 1989 Aug; 19(1):31-44. PubMed ID: 2772658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.